Filter
333
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
38
New Publications
114
Language
Document type
No document type
186
Guidelines
53
Studies & Reports
40
Strategic & Response Plan
20
Manuals
18
Fact sheets
6
Training Material
5
Situation Updates
4
Infographics
1
Countries / Regions
Kenya
18
Uganda
14
India
13
Western and Central Europe
13
Nigeria
12
Ghana
11
Eastern Europe
11
Global
11
Nepal
9
South Africa
9
Ethiopia
8
Namibia
8
Rwanda
7
Sierra Leone
6
Malawi
6
Tanzania
5
South–East Asia Region
5
Liberia
4
Congo, Democratic Republic of
4
Zambia
4
Cambodia
4
Bangladesh
4
West and Central Africa
4
Zimbabwe
3
Lesotho
3
East and Southern Africa
3
Latin America and the Carribbean
3
Africa
3
Russia
3
Senegal
2
Philippines
2
Syria
2
Indonesia
2
Mozambique
2
Sudan
2
Benin
2
Eswatini/ Swaziland
2
Ukraine
2
Botswana
2
Madagascar
2
Myanmar / Burma
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Asia
2
Cameroon
1
Haiti
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Laos
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
164
Clinical Guidelines
44
Public Health
11
Capacity Building
6
Women & Child Health
6
Pharmacy & Technologies
4
Key Resources
2
Toolboxes
TB
44
Pharmacy
37
AMR
28
COVID-19
22
HIV
16
NTDs
13
NCDs
4
Ebola
3
Refugee
2
Specific Hazards
2
Caregiver
2
Cholera
1
Polio
1
Rapid Response
1
Global Health Education
1
Planetary Health
1
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwa
...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re
...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities
...
National HIV Strategic Plan 2016-2021
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar
...
National Tuberculosis and Leprosy Conrol Programme
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati
...
